Closure and redistribution of assets from a Canadian R&D facility
Asset transfer to three international locations including the US, Singapore and Switzerland
700 assets
Phased relocation
Trade Compliance support
Scope of Work
Large volume of Tier 2 and 3 high value, sensitive assets
Specialist crating of all OEM assets which included the Aport double floating deck crate, shock and tilt monitors
Liaison with disposition provider to distribute sold assets
Three separate modes of transport, air, road and sea
Project Coordination
A full project team worked on the ground from Aport including destination teams in the US and Singapore
There was a 9 month pre-planning period with extensive focus on reducing the overall project timelines to ensure maximum efficiency and uptime of assets once relocated
Significant Challenges
US FDA pre-clearance required due to delivery timelines required Multiple areas packed simultaneously and often out of sequence